Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

John Hornberger

Biographic Data

ID9110944
NAMEJohn Hornberger
GIVEN NAMESJohn
FAMILY NAMEHornberger
SIGNATUREHORNBERGER J
AFFILIATIONSStanford University
ORCID0000-0001-9888-2205
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
AUTHOR COUNT5
EDITOR COUNT0
FIRST PUBLICATION YEAR1995
LATEST PUBLICATION YEAR2009
H-INDEX0
  • Cost consequences of HIV-associated lipoatrophy

    John Hornberger, Rukmini Rajagopalan et al.•ARTICLE•AIDS Care•2009

    HIV-associated lipoatrophy may affect up to 35% of patients who have received antiretroviral (ARV) regimens for more than one year, and may result in depression, social isolation, and career barriers. Interventions including the injection of dermal fillers for restoration of facial fat loss are being used for treating HIV-associated lipoatrophy. Since reimbursement is often lacking, patients must consider the pros and cons of such interventions, …

  • A cost-benefit analysis of a cardiovascular disease prevention trial, using folate supplementation as an example

    John Hornberger•ARTICLE•American Journal of Public Health•1998•References: 29

    OBJECTIVES: This study illustrates a cost-benefit analysis of clinical trial design, using as an example a trial of folate supplementation to prevent cardiovascular disease. METHODS: Bayesian statistical and decision-analytic techniques were used to estimate the cost-benefit and sample size of a placebo-controlled trial of folate targeted to US citizens, aged 35 to 84 years, with elevated serum homocysteine levels. The main end point is event-fre…

  • Mortality, Hospital Admissions, and Medical Costs of End-Stage Renal Disease in the United States and Manitoba, Canada

    John C Hornberger John C Hornberger, John Hornberger et al.•ARTICLE•Medical Care•1997•References: 27

    OBJECTIVES: National registry data suggest that mortality rates among patients with end-stage renal disease are lower in Canada than in the United States. Casemix and treatment variables, although limited in such instances, do not explain this difference. Using a more complete set of casemix and treatment variables from clinical databases, this study assesses mortality, hospital admission, and the cost of medical care for patients with end-stage …

  • Eliminating Language Barriers for Non-English-Speaking Patients

    John C Hornberger, John Hornberger et al.•ARTICLE•Medical Care•1996•References: 17

    OBJECTIVES: More than 31 million persons living in the United States do not speak English, therefore language discordance between the clinician and patient may hinder delivery of cost-effective medical care. A new language service was developed in which interpreters are trained in the skills of simultaneous interpretation commonly used at international conferences. The interpreters are linked from a remote site to headsets worn by the clinician a…

  • Minimum Data Needed on Patient Preferences for Accurate, Efficient Medical Decision Making

    John C Hornberger, John Hornberger et al.•ARTICLE•Medical Care•1995

    Involving patients in their health care decisions improves patient satisfaction and outcomes, but can be costly because of the materials and time needed to discuss the many issues that constitute a medical problem. The authors present a framework for identifying the minimum data needed on patient preferences for accurate medical decision making. The method is illustrated for the decision of whether patients with end-stage renal disease should und…

No prominent works on this page.

  • Minimum Data Needed on Patient Preferences for Accurate, Efficient Medical Decision Making

    John C Hornberger, John Hornberger et al.•ARTICLE•Medical Care•1995

    Involving patients in their health care decisions improves patient satisfaction and outcomes, but can be costly because of the materials and time needed to discuss the many issues that constitute a medical problem. The authors present a framework for identifying the minimum data needed on patient preferences for accurate medical decision making. The method is illustrated for the decision of whether patients with end-stage renal disease should und…

  • Eliminating Language Barriers for Non-English-Speaking Patients

    John C Hornberger, John Hornberger et al.•ARTICLE•Medical Care•1996•References: 17

    OBJECTIVES: More than 31 million persons living in the United States do not speak English, therefore language discordance between the clinician and patient may hinder delivery of cost-effective medical care. A new language service was developed in which interpreters are trained in the skills of simultaneous interpretation commonly used at international conferences. The interpreters are linked from a remote site to headsets worn by the clinician a…

  • Mortality, Hospital Admissions, and Medical Costs of End-Stage Renal Disease in the United States and Manitoba, Canada

    John C Hornberger John C Hornberger, John Hornberger et al.•ARTICLE•Medical Care•1997•References: 27

    OBJECTIVES: National registry data suggest that mortality rates among patients with end-stage renal disease are lower in Canada than in the United States. Casemix and treatment variables, although limited in such instances, do not explain this difference. Using a more complete set of casemix and treatment variables from clinical databases, this study assesses mortality, hospital admission, and the cost of medical care for patients with end-stage …

  • A cost-benefit analysis of a cardiovascular disease prevention trial, using folate supplementation as an example

    John Hornberger•ARTICLE•American Journal of Public Health•1998•References: 29

    OBJECTIVES: This study illustrates a cost-benefit analysis of clinical trial design, using as an example a trial of folate supplementation to prevent cardiovascular disease. METHODS: Bayesian statistical and decision-analytic techniques were used to estimate the cost-benefit and sample size of a placebo-controlled trial of folate targeted to US citizens, aged 35 to 84 years, with elevated serum homocysteine levels. The main end point is event-fre…

  • Cost consequences of HIV-associated lipoatrophy

    John Hornberger, Rukmini Rajagopalan et al.•ARTICLE•AIDS Care•2009

    HIV-associated lipoatrophy may affect up to 35% of patients who have received antiretroviral (ARV) regimens for more than one year, and may result in depression, social isolation, and career barriers. Interventions including the injection of dermal fillers for restoration of facial fat loss are being used for treating HIV-associated lipoatrophy. Since reimbursement is often lacking, patients must consider the pros and cons of such interventions, …

Medicine (5 works) · Intensive care medicine (3 works) · Internal Medicine (3 works) · Internal Medicine (3 works) · Alternative medicine (2 works) · Computer Science (2 works) · Disease (2 works) · Statistics (2 works) · Advanced Causal Inference Techniques (1 works) · Antiretroviral therapy (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae